UMIN ID: UMIN000002099
Registered date:21/06/2009
Effects of metformin and pioglitazone on serum pentosidine levels in type 2 diabetes mellitus
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Type 2 diabetes mellitus |
| Date of first enrollment | 2007/06/01 |
| Target sample size | 80 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | treatment with metformin treatment with pioglitazone treatment of sulfonylurea or insulin |
Outcome(s)
| Primary Outcome | the effects of metformin or pioglitazone on serum pentosidine levels |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | Not applicable |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | Nobody had hepatic or renal dysfunction or nutritional derangements. Patients who had taken metformin or pioglitazone in the past were excluded from this study. |
Related Information
| Primary Sponsor | Internal Medicine 1, Shimane University Faculty of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Self funding |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Ippei Kanazawa |
| Address | Japan |
| Telephone | |
| ippei.k@med.shimane-u.ac.jp | |
| Affiliation | Shimane University Faculty of Medicine Internal Medicine 1 |
| scientific contact | |
| Name | Ippei Kanazawa |
| Address | 89-1 Enya-cho, Izumo, Shimane Japan |
| Telephone | |
| Affiliation | Shimane University Faculty of Medicine Internal Medicine 1 |